Whooping cough- known
medically as pertussis- is a highly contagious respiratory tract infection.
 Although it initially resembles an ordinary cold, whooping cough may
eventually turn more serious, particularly in infants.  The best way to
prevent it is through vaccinations.  The childhood vaccine is called DTaP.
 The whooping cough booster vaccine for adolescents and adults is called
Tdap.  Both DTaP and Tdap protect against whooping cough, tetanus and
diphtheria.  Recommended vaccine ages are listed below:
| 
Age/Status | 
Recommendations | 
| 
Birth through 
6 years | 
DTaP is routinely
  recommended at 2, 4, and 6 months, at 15 through 18 months, and at 4 through
  6 years. | 
| 
7 through 10 years | 
Tdap is recommended for
  children ages 7 through 10 years who are not fully vaccinated (see not 1)
  against pertussis: 
·        
  Single
  dose of Tdap for those not fully vaccinated or  
·        
  If
  additional doses of tetanus and diphtheria toxoid-containing vaccines are
  needed, then children aged 7 through 10 years should be vaccinated according
  to the catch-up schedule, with Tdap preferred as the first dose. | 
| 
11 through 18 years | 
Tdap is routinely
  recommend as a single dose for those 11 through 18 years of age with
  preferred administration at 11 through 12. 
  If adolescents (13-18 miss getting Tdap at 11-12 yrs. then administer
  at the next patient encounter or sooner if that adolescent has close contact
  with infants. | 
| 
19 years and older | 
Andy adult 19 yrs. of
  age or older who has not received a dose of Tdap should get one as soon as
  feasible- to protect themselves and infants. 
  This Tdap booster dose can replace one of the 10-year Td booster
  doses.  Tdap can be administered
  regardless of interval since the previous Td dose.  Shorter intervals between Tdap and last Td
  may increase the risk of mild local reactogenicity but may be appropriate if
  your patient is at high risk for contracting pertussis, such as during an
  outbreak, or has close contact with infants. | 
| 
Pregnant women | 
Pregnant women should
  get a dose of Tdap during each pregnancy, preferable at 27 through 36 weeks gestation.  By getting Tdap during pregnancy, maternal
  pertussis antibodies transfer to the newborn, likely providing protection
  against pertussis in early life, before the baby starts getting DTaP
  vaccines.  Tdap will also help protect
  the mother at time of deliver, making her less likely to transmit pertussis to
  her infant.  It is important that all
  family members and caregivers of the infant are up-to0date with their
  pertussis vaccines (DTaP or Tdap, depending on age) before coming into close
  contact with the infant.  | 
| 
Health Care
  Personnel   | 
A single dose of Tdap is
  recommended for health care personnel who have not previously received Tdap
  as an adult and have direct patient contact. 
  Tdap vaccination can protect health care personnel against pertussis
  and help prevent them from spreading it to their patients.  Priority should be given to vaccinating
  those who have direct contact with babies younger than 12 months. 
Tdap can be administered
  regardless of interval since the previous Td dose.  However, shorter intervals between Tdap and
  last Td may increase the risk of mild local reactogenicity. | 
Taken from the CDD
at http://www.cdc.gov/Vaccines/vpd-vac/pertussis/default.htm
POSTED BY: Ilana Kutinsky,
DO 
 
 
No comments:
Post a Comment